SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-025309
Filing Date
2021-10-13
Accepted
2021-10-13 16:05:31
Documents
15
Period of Report
2021-10-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42075
2 ex10-1.htm EX-10.1 83092
3 ex10-2.htm EX-10.2 65826
4 ex10-3.htm EX-10.3 64843
  Complete submission text file 0001493152-21-025309.txt   470553

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atrx-20211008.xsd EX-101.SCH 3034
6 XBRL LABEL FILE atrx-20211008_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE atrx-20211008_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3174
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 211321293
SIC: 2834 Pharmaceutical Preparations